Figure S1 from High Detection Rates of Pancreatic Cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9
Year: 2023
Type: other
Abstract: Supplemental Figure 1 shows the predicted probability of cancer from the cross-validated MDM rForest model, demonstrating no significant difference in model performance based on tumor size, tumor location, presence of symptoms at the time of diagnosis, or timing of biopsy in relationship to blood draw.
Authors: Shounak Majumder, William R. Taylor, Patrick H. Foote, Calise K. Berger, Chung Wah Wu, Douglas W. Mahoney, William R. Bamlet, Kelli N. Burger, Neil Postier, Jaime de la Fuente, Karen A. Doering, Graham P. Lidgard, Hatim T. Allawi, Gloria M. Petersen, Suresh T. Chari, David A. Ahlquist, John B. Kisiel
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361940429